<DOC>
	<DOCNO>NCT00264433</DOCNO>
	<brief_summary>N-cadherin , protein involved blood vessel cell binding , increase cancer progress , surface many tumor cell . ADH-1 block N-cadherin . This study test safety effect ADH-1 subject specific incurable , solid tumor protein biomarker call N-cadherin . This study examine clinical activity ADH-1 .</brief_summary>
	<brief_title>A Study Safety Effects ADH-1 Given Intravenously Single Agent</brief_title>
	<detailed_description />
	<criteria>Signed write informed consent Male female patient &gt; = 18 year age solid tumor ( ) refractory standard curative therapy curative therapy exist Histologically proven advance and/or metastatic solid tumor one follow histology : nonsmall cell lung cancer ( squamous nonsquamous histology ) , gastroesophageal carcinoma ( squamous adenocarcinoma histology ) , renal cell carcinoma , hepatocellular carcinoma , adrenocortical carcinoma Measurable disease Immunohistochemical evidence Ncadherin expression ( least 1+ positive ) archive fresh tumor tissue Adequate performance status organ function , evidence hematological biochemical blood test electrocardiogram ( ECG ) Receipt ADH1 prior clinical study Chemotherapy , radiotherapy , investigational drug within 30 day study entry History spinal cord compression , history primary brain tumor ( ) brain metastasis ( know suspect ) unless lesion completely resolve follow appropriate treatment recurrence least 6 month History tumor show clinically significant evidence active bleeding ( e.g. , gross hemoptysis , hematemesis , hematuria , melena , bleed superficial tumor ) within 12 week study entry Stroke , major surgery , major tissue injury within 30 day study entry History : uncontrolled congestive heart failure , coronary artery disease , life threaten arrhythmia ; myocardial infarction le 12 month prior study entry ; significant ECG abnormality ; know hypercoagulable state</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2007</verification_date>
	<keyword>Cancer ; Tumors ; Neoplasms ; Anticarcinogenic Agents ; Antineoplastic Agents</keyword>
	<keyword>Cadherins ; Non-Small-Cell Lung Carcinoma ; Esophageal Cancer ; Gastric Cancer ; Renal Cell Carcinoma ; Hepatocellular Carcinoma ; Adrenocortical Carcinoma</keyword>
</DOC>